Lobbying

Eyecare Partners's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q3 2025–Q2 2026 total $100K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Eyecare Partners

Latest quarter
$0
Q2 2026 · 1 reports
Last 12 months
$100K
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Eyecare Partners lobbying by quarter
Eyecare Partners lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$50K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$50K1
Q1 2026$01
Q2 2026$01

Policy issues the reports name

  • Health issues13 reports
  • Medicare and Medicaid13 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES6 reports
  • SENATE6 reports

Firms it paid

Firm
Alston & Bird$530K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/20for Q2Alston & BirdUnder $5,000
04/20for Q1Alston & BirdUnder $5,000
01/20for Q4 2025Alston & Bird$50K
25/10/20for Q3 2025Alston & Bird$50K
25/07/21for Q2 2025Alston & Bird$50K
25/04/21for Q1 2025Alston & Bird$50K
25/01/21for Q4 2024Alston & Bird$50K
24/10/21for Q3 2024Alston & Bird$50K
24/07/22for Q2 2024Alston & Bird$50K
24/04/22for Q1 2024Alston & Bird$20K
24/01/22for Q4 2023Alston & Bird$20K
23/10/20for Q3 2023Alston & Bird$20K
23/07/19for Q2 2023Alston & Bird$20K
23/04/20for Q1 2023Alston & Bird$50K
23/01/20for Q4 2022Alston & Bird$50K